Bills · 2025-2026 Regular Session
Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE)
Drugs Legislature — Tax exemptions joint survey committee on Sales tax — Exemption Sanitation and sewerage management
- Introduced, stopped here
- Passes Senate, not reached
- Passes Assembly, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill creates a sales and use tax exemption for the sale of over-the-counter drugs.
Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill.
What it would cost
Fiscal estimates filed by state agencies, as official PDFs
Sponsors
Full history
- Feb 17, 2026 · Senate
Introduced by Senators Smith, Wirch, Carpenter, Ratcliff, Hesselbein and Spreitzer; cosponsored by Representatives Sheehan, Sinicki, Snodgrass, Joers, Hysell, Miresse, Stubbs, Palmeri, Johnson, Roe and Neubauer
- Feb 17, 2026 · Senate
Read first time and referred to Committee on Agriculture and Revenue
- Mar 4, 2026 · Senate
Fiscal estimate received
- Mar 13, 2026 · Senate
Senator Keyeski added as a coauthor
- Mar 18, 2026 · Senate
Representative Anderson added as a cosponsor
- Mar 19, 2026 · Senate
Representative J. Jacobson added as a cosponsor
- Mar 23, 2026 · Senate
Failed to pass pursuant to Senate Joint Resolution 1